We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 54,184

Is there a Doctor in the House? How the Travel Ban Could Impact the Healthcare Industry
  • Ogletree Deakins
  • USA
  • March 29 2017

On March 15, 2017, a federal judge in Hawaii issued a ruling that enjoined the Trump administration's revised Executive Order intended to suspend


Seventh Circuit Grants Interlocutory Appeal in Rx Discount Program Qui Tam Suit to Answer Several Important Questions
  • Ropes & Gray LLP
  • USA
  • March 29 2017

In United States ex rel. Garbe v. Kmart Co., 824 F.3d 632 (7th Cir. 2016), the Seventh Circuit granted interlocutory appeal following numerous motions


Janssen v. Celltrion, Damages: “Patent Dance” May Determine Availability of Lost Profits
  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • USA
  • March 29 2017

On March 2, 2017, the United States District Court for the District of Massachusetts issued an order in Janssen v. Celltrion explaining that an


FBI Warns of Cybersecurity Risk from FTPs
  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • USA
  • March 29 2017

Last week, the FBI issued guidance specifically applicable to medical and dental facilities regarding the cybersecurity risk of File Transfer


Comments to Draft Chicago Pharmaceutical Sales Representative License Rules Due April 2, 2017
  • Cooley LLP
  • USA
  • March 29 2017

As previously discussed, pharmaceutical sales representatives that conduct business in the City of Chicago will need to be licensed as of July 1, 2017


Proposed Employee Wellness Legislation Might Undermine Protections of GINA
  • Akerman LLP
  • USA
  • March 28 2017

Employees who don’t want to disclose genetic information about themselves and their families to their employers may have to pay a stiff price for that


Repeal Efforts Fail (for now): Can Obamacare Survive?
  • Cozen O'Connor
  • USA
  • March 28 2017

With the House GOP pulling the American Health Care Act (AHCA) due to lack of sufficient support even within its own party, Obamacare is not out of


The Future of the Affordable Care Act Week 8: An Employer’s Guide to the Collapse of the American Health Care Act (Spoiler Alertthe News is Not all Bad)
  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • USA
  • March 28 2017

The stunning failure of the U.S. House of Representatives to pass the American Health Care Act (AHCA) (which we previously reported on here) has


Government Solidifies Victory Blocking Chicago Hospital Merger
  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • USA
  • March 28 2017

The Federal Trade Commission (“FTC”) and the State of Illinois successfully concluded their challenge to the proposed merger of Advocate Health Care


FDA User Fee Hearings Picking Up Steam on Capitol Hill
  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • USA
  • March 28 2017

As we noted previously in our introductory blog post on the 2017 User Fee Act (UFA) reauthorization process, the first UFA hearing on Capitol Hill